NEW YORK (GenomeWeb News) – Hologic this week announced a handful of executive appointments and the impending retirement of its CFO.

The firm said that it has named Eric Compton to the newly-established position of chief operating officer. He will be responsible for overseeing all of the firm's commercial operations in the US, and its global research and development, manufacturing, and service operations. Compton most recently served as worldwide president of Johnson & Johnson's Ortho Clinical Diagnostics business.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.